Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anthera Pharmaceuticals, Inc. (ANTH)
:ANTH
Holding ANTH?
Track your performance easily
ANTH Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume475.00
Average Volume (3M)3.80K
Market Cap
$26.00
Enterprise ValueN/A
Total Cash (Recent Filing)$25.95M
Total Debt (Recent Filing)$15.10M
Price to Earnings (P/E)―
Beta9.56
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,179,000
10 Day Avg. Volume463
30 Day Avg. Volume3,803
Standard Deviation40.61
R-Squared0.00625
Alpha12.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
―
Insiders
0.04% Other Institutional Investors
99.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ANTH FAQ
What was Anthera Pharmaceuticals, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Anthera Pharmaceuticals, Inc.’s market cap?
Anthera Pharmaceuticals, Inc.’s market cap is $26.00.
When is Anthera Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Anthera Pharmaceuticals, Inc.’s earnings last quarter?
Anthera Pharmaceuticals, Inc. released its earnings results on Nov 06, 2017. The company reported -$0.58 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.58.
Is Anthera Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts Anthera Pharmaceuticals, Inc.’s price is currently Overvalued.
Does Anthera Pharmaceuticals, Inc. pay dividends?
Anthera Pharmaceuticals, Inc. does not currently pay dividends.
What is Anthera Pharmaceuticals, Inc.’s EPS estimate?
Anthera Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anthera Pharmaceuticals, Inc. have?
Anthera Pharmaceuticals, Inc. has 26,179,000 shares outstanding.
What happened to Anthera Pharmaceuticals, Inc.’s price movement after its last earnings report?
Anthera Pharmaceuticals, Inc. reported an EPS of -$0.58 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Anthera Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in ANTH
---
Company Description
Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA.
---
Atara Biotherapeutics
―
XTL Biopharmaceuticals Ltd. Sponsored ADR
―
Durect
―
ACADIA Pharmaceuticals
―
BioVie
―
Cellectar Biosciences
―
---